Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
03/2012
03/08/2012US20120058981 Androgen pharmaceutical composition and method for treating depression
03/08/2012US20120058975 Phosphonate Compounds
03/08/2012US20120058966 Sphingosine Kinase Inhibitor Prodrugs
03/08/2012US20120058965 Methods and systems for modulating hormones and related methods, agents and compositions
03/08/2012US20120058960 Feedback prodrug
03/08/2012US20120058944 Bone morphogenetic protein 2 (bmp2) variants with reduced bmp antagonist sensitivity
03/08/2012US20120058942 Methods for controlling blood-glucose levels in insulin-requiring subjects
03/08/2012US20120058941 Glucopyranoside compound
03/08/2012US20120058940 Azinone-substituted azapolycycle mch-1 antagonists, methods of making, and use thereof
03/08/2012US20120058939 Azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine mch-1 antagonists, methods of making, and use thereof
03/08/2012US20120058938 Nutritional composition inducing a postprandial endocrine response
03/08/2012US20120058210 Extract of fraxinus excelsior seeds and therapeutic applications therefor
03/08/2012US20120058207 Anti-diabetic nutraceutical composition from palm leaf extract
03/08/2012US20120058205 Compositions and treatment regimes for reducing inflammation, end-organ injury, and/or systemic endotoxemia
03/08/2012US20120058200 Process for the preparation of lanthanum carbonate dihydrate
03/08/2012US20120058195 Microencapsulation of bioactive substances and methods of making the same
03/08/2012US20120058190 Food containing prolactin
03/08/2012US20120058189 Process for making a crystalline zilpaterol salt
03/08/2012US20120058188 Lipid encapsulated interfering rna
03/08/2012US20120058180 Liver-specific Nanocapsules and Methods of Using
03/08/2012US20120058173 Selective starch feeding protocol
03/08/2012US20120058171 Zoo-technical drug delivery device
03/08/2012US20120058160 Particulate materials
03/08/2012US20120058157 Methods of Treating Cardiovascular Disorders Associated with Atherosclerosis
03/08/2012US20120058137 Efficient transport into white blood cells
03/08/2012US20120058132 Treatment of glycogen storage disease type II
03/08/2012US20120058125 Methods relating to peripheral administration of nogo receptor polypeptides
03/08/2012US20120058119 Human tumor necrosis factor tr21 and methods based thereon
03/08/2012US20120058116 Fgfr1c antibody combinations
03/08/2012US20120058105 Method of treatment of vascular complications
03/08/2012US20120058102 Pharmacologically induced transgene ablation system
03/08/2012US20120058094 Compositions and methods for treating obesity and related disorders by characterizing and restoring mammalian bacterial microbiota
03/08/2012US20120058089 Treatment of organ injuries and burns using placental stem cells
03/08/2012US20120058078 Assay for the detection of factors that modulate the expression of ingap
03/08/2012CA2811143A1 Orally administered composition and dietary composition having serum lipid improving effect
03/08/2012CA2810393A1 Method of preparing 3-amino-4-(2-oxo-piperidin-1-yl)-butyric acid derivative for synthesizing medicament
03/08/2012CA2810071A1 Substituted tetrahydropyrrolopyrazine derivatives
03/08/2012CA2809958A1 Use of the fetal reprogramming of a ppar ? agonist
03/08/2012CA2809493A1 Peptide or peptide complex binding to .alpha.2 integrin and methods and uses involving the same
03/08/2012CA2809321A1 Use of ave0010 for the manufacture of a medicament for the treatment of diabetes mellitus type 2
03/08/2012CA2809222A1 Bace inhibitors for use in the treatment of diabetes
03/08/2012CA2809194A1 Kinases as targets for anti-diabetic therapy
03/08/2012CA2809112A1 Cyclic amide derivative
03/08/2012CA2808909A1 Salts of lorcaserin with optically active acids
03/08/2012CA2808904A1 Non-hygroscopic salts of 5-ht2c agonists
03/08/2012CA2808900A1 Fast-dissolve dosage forms of 5-ht2c agonists
03/08/2012CA2808890A1 Administration of lorcaserin to individuals with renal impairment
03/07/2012EP2426135A1 Urea derivative having pi3k inhibitory activity
03/07/2012EP2426117A1 Thiophene derivative
03/07/2012EP2426113A1 Carbinol compound having heterocyclic linker
03/07/2012EP2425722A2 Drugs and food products for hypophosphoric normo-, hyper- and hypoproteic diets, and hypophosphoric beverages
03/07/2012EP2424870A1 Therapeutic agents 713
03/07/2012EP2424865A2 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
03/07/2012EP2424861A1 Indole-2-carboxamide derivative
03/07/2012EP2424860A1 Heteroarylthiomethyl pyridine derivative
03/07/2012EP2424844A1 Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
03/07/2012EP2424555A2 Method of reducing fat accumulation and inducing weight loss
03/07/2012EP2424545A1 Natural molecules extracted from bergamot tissues, extraction process and pharmaceutical use
03/07/2012EP2424530A2 Method and composition for treating diabetic ketoacidosis
03/07/2012EP2424519A1 Use of pufas to treat nerve damage
03/07/2012EP2188253B1 Indol-2-one derivatives disubstituted in 3-position, preparation thereof and therapeutic use thereof
03/07/2012EP1979331B1 Trisubstituted amine compounds as inhibitors of -cholesteryl ester transfer protein cetp
03/07/2012EP1754702B1 Epigallocatechin dimers or trimers having lipase inhibitory activity and/or antioxidative activity
03/07/2012EP1694644B1 N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein b
03/07/2012EP1585518B1 Peptide deformylase inhibitors
03/07/2012EP1519732B1 Use of vasopeptidase inhibitors in the treatment of nephropathy
03/07/2012EP1438377B1 Cholesterol lowering structured lipids with omega 3 pufa
03/07/2012CN1835943B 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and uses thereof
03/07/2012CN102369023A Oligosaccharide-protein conjugates
03/07/2012CN102369018A Treatment of diabetes and metabolic syndrome
03/07/2012CN102369015A Peptides, pharmaceutical compositions comprising same and uses thereof
03/07/2012CN102368913A Reduction of risk of obesity
03/07/2012CN102368912A Use of whole grain materials with high resistant starch for satiety, reduction of food intake and weight management
03/07/2012CN102367227A Stable Levocarnitine compound and pharmaceutical composition thereof
03/07/2012CN102366605A Traditional Chinese medicine preparation for treating hypertension and hyperlipidemia, and its preparation method
03/07/2012CN102366596A Medicine for treating diabetes and preparation method thereof
03/07/2012CN102366595A Medicine for treating diabetes and preparation method thereof
03/07/2012CN102366541A Traditional Chinese medicine composition for treatment of diabetes
03/07/2012CN102366540A Medicine for treating diabetes and its preparation method
03/07/2012CN102366518A Method for ultrasonic assisted aqueous two-phase extraction of total dioscin
03/07/2012CN102366498A Traditional Chinese medicine composite for treating diabetes and preparation method thereof
03/07/2012CN102366497A Medicinal compound preparation for treating diabetes and preparation method of medicinal compound preparation
03/07/2012CN102366496A Application of Chinese herbal medicine rhizoma alismatis extract in preparation of weight-reducing and lipid-lowering medicaments or in preparation of medicaments with lipase activity inhibition
03/07/2012CN102366495A Self-heated traditional Chinese medicine (TCM) emplastrum for lowering lipid and losing weight
03/07/2012CN102366481A Medicine for treating diabetes and preparation method thereof
03/07/2012CN102366480A Medicine for treating diabetes and preparation method thereof
03/07/2012CN102366443A Medicine for treating diabetes and preparation method thereof
03/07/2012CN102366433A Application of Chinese medicinal chrysanthemum extract in preparing weight-losing and lipid-lowering medicaments or lipase activity-inhibiting medicaments
03/07/2012CN102366429A Application of extract of Chinese herbal medicine notopterygium root in preparing medicines for reducing weight and fat or medicines having effect of inhibiting lipase activity
03/07/2012CN102366428A Applications of extracts from Chinese herbal medicine Oroxylum indicum in preparation of slimming and lipid lowering medicine or preparation of medicine with inhibition effect on activity of lipase
03/07/2012CN102106957B Chinese medicinal composition for treating hyperlipidemia
03/07/2012CN101919866B Method for inhibiting content decrease of Vit D2 after sterilization
03/07/2012CN101804137B Chinese medicine film preparation used in plasma filtering device
03/07/2012CN101732441B Extract of effective part of sibiraea augustata(rehd.) hand-mazz for preventing adiposity and lowering hyperlipoidemia, preparation method and application thereof
03/07/2012CN101716332B Use of phycocyanin for preventing and treating diabetes mellitus
03/07/2012CN101626764B Amino acid composition
03/07/2012CN101564384B Multivitamin aqueous solution preparation
03/07/2012CN101432263B Substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
03/07/2012CN101264066B Rutin osmotic pump preparations and preparation thereof
03/07/2012CN101143131B Method for preparing human insulin inhaled dry powder using with supercritical fluid technology
1 ... 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 ... 1298